Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
By Murray B. Stein, MD, FRCPC
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
By Charles B. Nemeroff, MD, PhD
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
By Madhukar Trivedi, MD
Nota de los editores
Aligerando la carga: la depresión en Latinoamérica
Dr. Miguel R. Jorge y Dr. Juan E. Mezzich
Patricia Pilkinton, Carlos Berry, Seth Norrholm, Al Bartolucci, Badari Birur, Lori L. Davis
By Leila Mnif, Rim Sellami, Jawaher Masmoudi
Androgens and the Aging Male
By Stuart N. Seidman, MD
COMPLICATED CASE HISTORIES
Antidepressant Induced Apathy Responsive to Dose Reduction
By Sreekant Kodela, Pavan Dontineni Venkata
Antipsychotic Medication in Adolescents Suffering from Schizophrenia: A Meta-Analysis of Randomized Controlled Trials
By Ignazio Ardizzone, Francesca Nardecchia, Arianna Marconi, Teresa I. Carratelli, Mauro Ferrara
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
By Kamila S. White, PhD and Susan D. Raffa, MA
Anxiety Disorders
Overview:
Vast Progress but a Long Journey Ahead
By Tracey M. Boudine
EVIDENCE-BASED MEDICINE
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
By Michael E. Thase, MD
Artículo original
Efectos cardiovasculares y recomendaciones en el uso de psicofarmacos
Dra. Ruby C. Castilla, Dra. Sandra R. Castilla y Dra. Wilma I. Castilla